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The use of and demand for echocardiography 
(ECHO) have shown a marked increase worldwide. [1] 
As a ‘special’ investigation it has the potential to pro­
vide accurate haemodynamic as well as anatomical 
information non­invasively at the bedside.[1­3]
Developing countries are showing a steady rise in non­communi­
cable diseases (NCDs), with cardiovascular diseases proving the largest 
burden in South Africa (SA).[4,5] The dual burden of communicable 
diseases and NCDs is disproportionately affecting vulnerable lower­
income groups in urban settings.[4] Ironically, patients accessing 
hospitals with the least available specialist expertise have been 
shown to have the highest number of comorbidities.[6] Access to 
investigations such as ECHO, traditionally and often exclusively at the 
hands of specialist cardiologists, remains restricted and uneven in SA.
Recent advances in the developed world include open­access 
echocardiography (OAE), which is requested and the results acted on 
by general practitioners, hand­held devices, and point­of­care studies 
by non­cardiologists.[2,7­9] Apart from their usefulness in screening 
patients, appropriate care can be implemented at an earlier stage 
and waiting times for, or referrals to, tertiary care can be reduced. 
The main limitation for the roll­out of ECHO to primary healthcare 
settings is the lack of training of personnel.[10]
A few recent studies have reviewed the utility of ECHO in large, 
mainly tertiary centres in the developed world.[11­13] The use is driven 
mainly by appropriate­use criteria (AUC). These AUC identify 
common clinical scenarios in which ECHO can be applied and aim 
at improving health outcomes by means of the equitable allocation 
of resources in cardiovascular imaging.[14] There is a paucity of 
data regarding the impact of ECHO in sub­Saharan Africa. Various 
definitions of impact and the different concepts of a district or 
general hospital limit the generalisability to resource­constrained 
areas, where, paradoxically, the clinical impact of ECHO may be of 
more value than the traditionally accepted clinical indications.
Objectives
To assess the clinical impact of an ECHO service in a district hospital 
in SA. Further conclusions on the demand to access and need for 
training in echocardiography were possible.
Methods
A prospective, descriptive, cross­sectional study was conducted at 
Victoria Hospital, a district­level hospital in Cape Town, SA, serving 
a patient population (in 2014) of nearly 600 000, mainly of low and 
middle socioeconomic status. The study cohort consisted of patients 
referred to the once­weekly ECHO service during the 14­week period 
between September 2013 and January 2014.
Recruitment of study participants was achieved on the day of the 
prebooked ECHO appointments. All in­ and outpatient referrals 
were considered, regardless of age and comorbidities. Patients unable 
to give written consent were excluded. Only screening transthoracic 
echocardiography (TTE) was included. It was performed by a 
registered cardiologist, accredited to perform ECHO.
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Background. The use of and demand for echocardiography (ECHO) has increased worldwide. In developed countries, this has not 
translated into improved access outside tertiary centres. Previous studies have favoured the appropriate use of ECHO over its clinical 
impact, limiting generalisability to resource­constrained settings.
Objectives. To assess the impact of an ECHO service at district hospital level in Cape Town, South Africa.
Methods. A prospective, cross­sectional study was performed. A total of 210 consecutive patients, referred to the ECHO clinic over a 
5­month period, were recruited. Transthoracic ECHO was evaluated in terms of its indication, new information provided, correlation with 
the referring doctor’s diagnosis and subsequent management plan. Impact included the escalation and de­escalation of treatment, as well 
as usefulness without a change in management.
Results. The results show that 83.8% of the patients’ management was impacted on by echocardiography. Valvular lesions were the 
main indication. The most frequent contribution was information provided towards the diagnosis of heart failure and assessment after 
myocardial infarction. Of the echocardiograms, 56.2% confirmed the referring doctor’s diagnosis, yet were still associated with a significant 
impact. The rational prescription of medication had the major impetus, followed by de­escalation of therapy and screening patients to 
determine referral to a tertiary facility.
Conclusion. ECHO has a positive impact on patient management outside tertiary settings, where the definition of impact appears to be 
different. The value of a normal study, screening prior to upstream referral and usefulness irrespective of change have been established. This 
should alert policy makers against restriction of access to ECHO and promote training of personnel in its use.
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EpiCalc (freeware, version 1.02, 2000) was 
used to calculate the sample size. It was 
assumed that 80% of management decisions 
would change following results of the ECHO. 
To achieve a confidence level of 95% with a 
precision of 5% (i.e. a margin of error of 
10%), a sample size of 245 patients was 
required.
Data were collected prospectively, as the 
ECHO was performed. A questionnaire 
concerning patient characteristics and 
medical history was completed by the 
participant with the help of a research 
assistant. The cardiologist who performed 
the ECHO completed a second questionnaire 
in order to establish the impact of the 
ECHO by assessing the indication for the 
investigation, new information obtained, 
correlation with the referring doctor’s 
diagnosis and the management plan 
thereafter. AUC were used to classify 
indications explicitly. The average waiting 
period was randomly calculated on four 
dates, reviewing the time until the next 
available appointment.
The cardiologist used a Toshiba Nemio 
machine with an adult ECHO probe PST­
25AT (1.8 ­ 4.2 mHz). The patients were 
screened in the supine and left lateral 
positions. Examinations were viewed in 
real time and done in standard trans­
thoracic views, parasternal long and short 
axis with apical four­chamber views; 
subxyphoid views were included when 
indicated. M­mode, 2D and colour flow 
Doppler were utilised. The ejection fraction 
was measured using the Teicholz method. 
Regional wall motion was visually evaluated 
in the abovementioned views. Continuous 
Doppler was not available on the machine, 
but colour flow Doppler was used when 
necessary. M­mode recording was done 
and printed out when deemed necessary, 
but not stored. The ECHOs performed 
were for screening purposes only and were 
not standard transthoracic evaluations. 
Even though some patients had repeated 
TTE, most patients did not have a baseline 
standard study.
Impact was classified according to adapted 
criteria (Table 1).[11­13]
Statistical analysis
Data were captured with Excel version 
14.0.0 (Microsoft, USA, 2011) and analysis 
was performed on Stata 12.0 (Statacorp, 
USA, 2011). Where data were not normally 
distributed (e.g. age), a Kruskal­Wallis test 
was used. The Pearson’s χ2 test or Fisher’s 
exact test (if the expected frequency of a 
group was smaller than five) was used to 
calculate the statistical significance of the 
different proportions. Statistical significance 
was accepted as p<0.05. Prevalence ratios 
were then calculated. Absent data were 
perceived as missing completely at random, as 
categorical data were collected as tick sheets.
Ethical considerations
This study was approved by the Health Science 
Research Ethics Committee of the University 
of Cape Town (HREC 382/2013). Each 
participant gave written consent to participate 
in the study, and a study number was allocated 
to each in order to ensure confidentiality.
Results
A total of 210 participants were recrui­
ted (Fig. 1). Approximately one­third 
of the patients did not attend on their 
appointment date. The majority of 
the participants were referred by the 
Department of Medicine, either from the 
ward or via the Outpatient Department 
(Table 2).
Self­reported and documented comorbi­
dities included 9 HIV­positive participants 
(4.3%), 5 with rheumatic heart disease 
(2.8%) and 4 with a previous mitral valve 
replacement (2.3%), all associated with 
impact. It was not documented whether 
these valve replacements were initially 
indicated for rheumatic heart disease. Of 
the participants, 131 (62.4%) had a history 
of smoking, one­third of these indicating a 
current smoking habit. Of those older than 
Patients booked for TTE (n=312)
Unbooked patients (n=29)
Did not consent (n=14) Consented (n=220) Did not attend (n=107)
Done by cardiologist
(n=210)
Not done by
cardiologist (n=10)
Fig. 1. Recruitment of participants.
Table 1. Clinical impact criteria
Impact level Description
Active Escalation More rational drug therapy
Confirmation of vegetation
Cardioversion required
Referred for further imaging (angiography or nuclear 
medicine study)
Referred to tertiary cardiology services
Other referrals: palliative care programme, disability grant 
assessment
De­escalation Reassurance of normal study, omitting further testing or 
avoiding further referral
No change, but 
clinically useful
Contesting clinical suspicion/diagnostic value
Repeat echo advised/monitoring purpose
Cleared for theatre
No impact Continue current management plan
Confirming clinical suspicion with no change in management
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16 years, 34 (17.4%) were employed, while 
29 (13.8%) were receiving disability grants 
and 63 (30.0%) were pensioners.
An average number of 17 ECHOs were 
performed per clinic during the study 
period. The average waiting time until the 
next available appointment was 89 days.
Clinical utility and association  
with impact
We found that 83.8% of TTEs had an impact 
on the patient’s management. In total, 51.0% of 
ECHOs resulted in an escalation of management, 
and 19.0% in de­escalation, while 13.8% had an 
impact without a change of management.
Valvular lesions were the main indication 
for referral (Table  3). Only one patient’s 
indication was seen as inappropriate when 
compared with the AUC.[14]
The major contribution of TTE was the 
information provided to aid the diagnosis 
of heart failure (29.0%) and ischaemic heart 
disease (23.8%) (Table 4). Of all participants, 
one­third had impaired left ventricular 
(LV) function. Three cases of apical 
thrombus were identified after myocardial 
infarction, which resulted in the initiation of 
anticoagulation therapy.
The most common valvular lesions 
identified, in order of prevalence, are 
listed in Table 4. Of these, mitral stenosis, 
discerning aortic scleroses from stenosis, 
identifying non­pathological murmurs 
and aortic regurgitations were statistically 
significantly associated with clinical impact. 
In addition to the five participants known 
to have rheumatic heart disease prior to the 
TTE, three further cases were diagnosed, 
the total prevalence being 3.8% in our study 
cohort.
Six participants were diagnosed with 
cor pulmonale and four with pulmonary 
hypertension; none of these was known 
to be suffering from chronic obstructive 
pulmonary disease.
Despite the fact that 56.2% of all TTEs 
(n=118) confirmed the referring doctor’s 
diagnosis, these ECHOs were still significantly 
linked to impact (confidence interval 0.64  ­ 
0.80). In 39.1% (n=82) the pre­referral diag­
nosis was contested and in 4.8% (n=10) it was 
unknown. Of the 34 TTEs that did not have 
an impact, 88.2% (n=30) correlated with the 
pre­referral diagnosis.
Spectrum of clinical impact
TTE was found to be most useful in the 
rational prescription of medication (n=80). 
Twenty­seven participants, one­fifth of 
those who had an escalation in manage­
ment, required referral to tertiary services 
(Fig.  2). Of these upstream referrals, 9 
patients were referred for surgery: 5 were 
for valve replacements, 3 for the correction 
of atrial septal defects and 1 for surgery of an 
atrial myxoma. Three patients, with severe 
disease, required referral to the hospital’s 
social worker for a disability grant.
De­escalation of care, with return to pri­
mary healthcare services, was recommended 
in 40 cases. Fifteen participants were offered 
reassurance for non­pathological murmurs 
and six participants for idiopathic chest 
pain, preventing further testing or referral 
to a higher level of care. The remainder 
benefited in that TTE ruled out cardiac 
sources of emboli, structural causes for 
Table 2. Characteristics of patients referred for TTE
Total impact No impact Total
Age (years), median (range or mean; SD) 52 (2 ­ 86) 60 (25 ­ 87) 53 (50; 20.13) 
Male, n (%) 90 (50.8) 18 (54.5) 108 (51.4)
Female, n (%) 87 (49.1) 15 (45.4) 102 (48.6)
Employed (>16 years old), n (%) 27 (16.7) 7 (21.2) 34 (17.4)
Pensioner, n (%) 49 (27.7) 14 (42.4) 63 (30.0)
Receiving DG, n (%) 24 (13.6) 5 (15.1) 29 (13.8)
Currently inpatient, n (%) 48 (27.1) 5 (15.1) 53 (25.2)
Referring facility, n (%)    
Medical ward 76 (42.9) 16 (48.5) 92 (43.8)
ED 34 (19.2) 7 (21.2) 41 (19.5)
MOPD 32 (18.1) 9 (27.3) 41 (19.5)
POPD 12 (6.8) ­ 12 (5.7)
CHC 12 (6.8) ­ 12 (5.7)
DH 5 (2.8) ­ 5 (2.4)
Private sector 1 (0.6) ­ 1 (0.5)
Other 4 (2.3) 1 (3.0) 5 (2.4)
Unknown source of referral 1 (0.6) ­ 1 (0.9)
Comorbidities, n (%)
Hypertension 91 (51.4) 28 (84.8) 119 (56.6)
Ischaemic heart disease 54 (30.5) 13 (39.4) 67 (31.9)
Hypercholesterolaemia 49 (27.7) 12 (36.4) 61 (29.5)
Diabetes mellitus 40 (22.6) 9 (27.3) 49 (23.3)
Cardiac failure 30 (18.2) 6 (18.2) 36 (17.1)
Atrial fibrillation 16 (9.0) 2 (6.1) 18 (8.6)
COPD 15 (8.5) 2 (6.5) 17 (8.1)
Known cardiomyopathy 13 (7.3) 3 (0.1) 16 (7.6)
Stroke 12 (6.8) 1 (3.0) 13 (6.2)
HIV 9 (5.1) ­ 9 (4.3)
Thyroid disease 8 (4.5) ­ 8 (3.8)
Obesity 4 (2.3) 2 (6.1) 6 (2.9)
Rheumatic heart disease 5 (2.8) ­ 5 (2.4)
Mitral valve replacement 4 (2.3) ­ 4 (1.9)
Habits, n (%)
Ex­smoker 70 (39.5) 15 (45.4) 85 (40.5)
Current smoker 38 (21.5) 8 (24.2) 46 (21.9)
Alcohol 30 (16.9) 9 (27.3) 39 (18.6)
Drugs (ex or current) 16 (9.0) 1 (3.0) 17 (8.1)
Total, n (%) 176 (83.8) 34 (16.2) 210 (100.0)
SD = standard deviation; DG = disability grant; ED = emergency department; MOPD = medical outpatients department; POPD 
= paediatric outpatients department; CHC = community healthcare centre; DH = (neighbouring) district hospital; COPD = 
chronic obstructive pulmonary disease.
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perceived arrhythmia (symptomatic or on 
electrocardiogram), pulmonary hyper­
tension and infective endocarditis.
ECHOs performed on 29 participants 
resulted in no change in management, but 
provided clinically useful information. Of 
these, two­thirds (n=16) were advised to 
have follow­up ECHOs (implying ongoing 
monitoring of their current condition). 
Eleven participants had ECHOs that 
contested the referring doctor’s diagnosis 
and two were deemed fit for surgery as part 
of an anaesthetic work­up.
Behavioural advice, for example direct 
advice on alcohol consumption, weight 
reduc tion and smoking cessation, was docu­
mented but not analysed. Three female 
patients with postpartum cardiomyopathy 
were advised against future pregnancies.
Discussion
We found that the majority (83.8%) of 
ECHOs had a positive impact on patients 
referred to a district hospital – a proportion 
much higher than that previously reported in 
developed country settings of 32 ­ 76%.[12,13] 
The diversity of patients’ ages, comorbidities 
and sources of referral revealed the broad 
value of this investigative modality. 
 
Stress ECG, 6, 14%Other, 6, 14%
CMO clinic, 6, 14%
Arrythymia
clinic, 6, 14%
Angiography,
6, 14%
Surgery, 9, 21%
Palliative care, 4, 9%
Fig. 2. Upstream referrals (impact or upstream 
referral clinic, number of cases, percentage of 
escalated management) after ECHO. (CMO = 
cardiomyopathy; ECG = electrocardiogram.)
Table 3. Indications and their association with clinical impact
Total impact
n (%) 
No impact
n (%)
Total
n (%)
Prevalence ratio
95% CI
Evaluation of valvular function 66 (37.5) 7 (20.6) 73 (34.8) 1.01 ­ 1.26
Unknown cause of heart failure 47 (26.7) 7 (20.6) 54 (25.7) 0.93 ­ 1.19
Post­myocardial infarction (for regional wall motion abnormalities) 26 (14.8) 9 (26.5) 35 (16.7) 0.61 ­ 0.90
Suspected hypertensive heart disease 18 (10.2) 16 (47.1) 34 (16.2) 0.38 ­ 0.72
Rhythm abnormality on ECG 31 (17.6) 1 (2.9) 32 (15.2) 1.08 ­ 1.31
Cardiomegaly, found clinically and radiologically, not known with CCF 22 (12.5) 2 (5.9) 24 (11.4) 0.97 ­ 1.27
Known cardiomyopathy 13 (7.4) 3 (8.8) 16 (7.6) 0.79 ­ 0.89
Evaluation of chest pain of unknown cause 14 (7.9) 2 (5.9) 16 (7.6) 0.86 ­ 1.27
History suggestive of arrhythmia, e.g. palpitation, light­headedness, 
presyncope or syncope
14 (7.9) ­ 14 (6.7) 0.78 ­ 0.88
Evaluation of cardiovascular source of embolus 9 (5.1) 1 (2.9) 10 (4.8) 0.87 ­ 1.34
Other 21 (11.9) 1 (2.9) 22 (10.5) ­
Total 176 (83.8) 34 (16.2) 210 (100.0)
ECG = electrocardiogram; CCF = congestive cardiac failure; Other = pulmonary hypertension, suspected infective endocarditis, new cardiomyopathy, evaluation of aortic disease, suspected 
pulmonary embolism.
Table 4. New information found on TTE
Total impact
n (%) 
No impact 
n (%)
Total
n (%)
Prevalence ratio 
95% CI
Detection of LV systolic 
dysfunction
57 (32.4) 9 (26.5) 66 (31.4) 0.93 ­ 1.18
Cause of heart failure 
established
28 (15.9) 6 (17.6) 34 (16.2) 0.82 ­ 1.16
Cause of heart failure 
confirmed
24 (13.6) 3 (8.8) 27 (12.9) 0.92 ­ 1.24
Wall motion abnormality 
found
28 (15.9) 4 (11.8) 32 (15.2) 0.91 ­ 1.22
Wall motion abnormality 
ruled out
12 (6.8) 6 (17.6) 18 (8.6) 0.48 ­ 0.92
LV hypertrophy 29 (16.5) 14 (41.2) 43 (20.5) 0.54 ­ 0.82
Congenital heart disease 4 (2.3) ­ 4 (1.9) 0.79 ­ 0.89
LV aneurysm 1 (0.6) ­ 1 (0.5) 0.78 ­ 0.89
Valvular lesions
Mitral regurgitation 56 (26.7) 5 (15.1) 61 (29.0) 1.01 ­ 1.25
Tricuspid regurgitation 34 (16.2) 5 (15.1) 39 (18.6) 0.90 ­ 1.19
Aortic sclerosis discerned 
from aortic stenosis
21 (11.9) 9 (26.5) 30 (14.3) 0.55 ­ 0.88
Aortic stenosis 17 (8.1) 3 (9.1) 20 (9.5) 0.83 ­ 1.23
Functional murmur 15 (8.5) ­ 15 (7.1) 0.77 ­ 0.88
Mitral stenosis 14 (6.7) ­ 14 (6.7) 0.78 ­ 0.88
Aortic regurgitation 8 (3.8) ­ 8 (3.8) 0.79 ­ 0.89
Total 176 (83.8) 34 (16.2) 210 (100.0)
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The value of a prospective study is that single ECHO assessment in 
a non­tertiary setting can immediately address a focused, clinical 
question or suspicion raised, and may have an immediate impact. 
Our definition of impact is different from previous larger impact 
studies, undertaken either in tertiary settings or in community 
hospitals with specialised cardiology services.[12,13] A few older studies 
done at district hospitals either reviewed the impact more than 30 
years ago, using only M­mode ECHO, or focused on intensive care 
units.[3,15,16] The lack of generalisability to current district hospital 
practice seems obvious, especially in resource­constrained settings.
We have established the role of ECHO in causing de­escalation in 
therapy and continuation of management at district hospital level. 
This potential for decreasing referral to tertiary specialists seems 
similar to other studies.[7,9,16] Previous studies have cautioned against 
undervaluing a study with normal findings.[8,11,17] This latter benefit 
was confirmed in 32.9% (n=69) of all the participants referred, 
without escalating management. Its use in screening prescreened 
patients is evident, with a particularly high impact level in all 
paediatric patients, mainly aiding in de­escalation of services relating 
to a murmur that had been auscultated prior to referral. This has 
been undervalued by previous studies.[12,15] Our study has shown that 
impact does not necessarily translate into a change in management – 
many patients without a change in clinical status require follow­up, 
which is seen as a valid indication in itself in early and late stages of 
cardiac disease.[14]
The major change in management proved to be rational prescription 
of medication. The other main benefit was determining which patients 
required up­referral to tertiary services, e.g. for cardiac surgery.
AUC are not used in SA. Nevertheless, only one participant’s 
indication could not be classified according to AUC, as the referral 
was for possible cardiac cause for seizures. This indicates the high 
level of appropriate use of ECHOs in our district hospital. The most 
common indication was suspected valve disease. Its significance 
could not be statistically linked to impact, perhaps owing to the small 
sample size achieved. New information gathered was nevertheless 
significant for mitral stenosis and aortic regurgitation, mirroring 
the finding of a previous audit of the beneficial value of ECHO in 
assessing diastolic (more than systolic) murmurs.[15] Three adult 
participants but no paediatric patients were newly diagnosed with 
rheumatic heart disease. A recent study in SA has shown the decrease 
in rheumatic heart disease in children in SA, which may be due 
to improved access to healthcare and an improved socioeconomic 
environment.[18] The use of ECHO as a screening tool for rheumatic 
heart disease has yet to be translated into impact on prognosis 
and effective secondary prophylaxis for subclinical disease. Results 
suggest that adults may benefit from screening more than children.[19]
Of all indications for ECHO, assessment of regional wall motion 
abnormalities and suspected hypertensive heart disease were 
statistically significantly associated with impact. The value of 
ECHO in defining prognosis in these two conditions has been 
described previously.[20,21] One study found that the evaluation of wall 
motion abnormalities constitutes the most statistically significant, 
independent prognostic data provided by TTE.[20] Although 
screening of all hypertensive patients has been recommended, as left 
ventricular hypertrophy itself implies a worse prognosis,[22] others 
assert that ECHO confirmation would probably not intensify the 
treatment of the hypertension itself.[22,23]
In our study, heart failure was the major indication for ECHO, 
as was the case in a systematic review of patients referred for 
OAE from primary care.[23] The role of TTE in providing new 
information in this context is nonetheless unsurpassed, by detecting 
LV dysfunction and either establishing or confirming the cause of 
failure.[17] This is of particular value in our setting, where heart 
failure is usually diagnosed and monitored by clinical means only. 
Despite two­thirds of the cohort having a smoking history, low 
numbers of cases of COPD and its complications were reported. 
Screening for and assessing cardiac complications, such as cor 
pulmonale and pulmonary hypertension, in patients with COPD 
can be useful, as both infer increased morbidity and mortality.[24] 
The diagnosis of a clinically unsuspected atrial myxoma in this 
small cohort was a finding that would otherwise have remained 
undetected.
Discrepancies between the results of the TTEs and the assessment 
of the referring clinician prior to the test were confirmed, as per 
previous studies.[25,26] It appears that the positive impact of TTE 
is independent of the clinical accuracy of the referring doctor. 
On the other hand, a lack of impact was nonetheless associated 
with accurate pre­referral assessment. This may indicate that a 
thorough history and physical examination may lessen the need for 
a diagnostic test.[25] Thirty­nine percent of the ECHOs disproved the 
pre­referral diagnosis.
In some of the participants who had had previous TTEs, repeat 
ECHO nevertheless had an important clinical impact. An earlier 
study found that the added diagnostic value of a repeat ECHO is 
significantly independent of whether the test had been performed 
previously.[25]
Approximately one­fifth of patients were referred from the 
hospital’s emergency department; this may indicate the need for 
training in question­focused, point­of­care studies. A review of 
TTEs performed by non­cardiologists showed an active change in 
management in 16 ­ 37% of patients in an emergency setting.[9]
Failure of referral of patients from primary healthcare facilities was 
found despite doctors being free to refer patients directly for TTEs; it 
is not clear whether the medical staff were unaware of the existence 
of the service. Notably, among the few patients in this study cohort 
who were referred from community healthcare settings, the ECHOs 
had an important impact.
The waiting time for the next available appointment was six times 
as long as the recommended time period of 2 weeks advised by the 
National Institute for Care Excellence guidelines for patients with 
chronic heart failure and after myocardial infarction.[27] A Dutch 
study of OAE reports a waiting time of 5 weeks.[7] In developing 
countries, a lack of resources and scarce skills may be the reason 
for this long waiting time. The poor socioeconomic status of our 
participants, including pensioners and those receiving disability 
grants, suggests a reliance on public sector facilities. The poor 
attendance for TTE appointments shows the undervaluing of this 
restricted resource. Non­attendance is often due to lack of funds for 
transport. Having this service only at a distant tertiary centre may 
add to poor attendance.
Study limitations
Our study does have limitations. The participants were referred 
from the hospital ward or outpatient departments and had been 
prescreened after being admitted via the emergency department 
or referred from a primary healthcare facility. This may overvalue 
the impact owing to a lower incidence of negative findings. Patients 
with acute cardiac illness, such as heart failure or myocardial 
infarction, may be more likely to benefit from ECHO. The inclusion 
of hospitalised patients probably increased the likelihood of 
appropriate referrals by doctors.[11] The ECHOs were performed 
by an experienced cardiologist, with this specialist assessment in 
itself likely to have an impact on patient management, causing 
impact to be overestimated. The risk of possible bias exists, as the 
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cardiologist was involved in the clinical decision­making process 
and management of participants. The study size was smaller than 
initially anticipated, mainly because of patients defaulting on their 
appointments.
Following the participants’ completion of the questionnaires, 
all data were checked to correlate with the clinical information 
in their folders. This allowed for more accurate analysis of the 
patient characteristics and the echocardiograms as well as their 
indications. Fifteen patient folders were missing and were not 
checked retrospectively.
The downstream risks of TTE, such as incorrect interpretation 
and residual anxiety despite a normal study, should not be disre­
garded.[1,14,28]
It would be important to gain insight into whether clinical impact 
and changes in management eventually translate into improved 
health outcomes in primary healthcare. These effects could be 
assessed in a follow­up study. Other than its clinical impact, the cost 
implications of a restricted resource should be studied. The benefits 
of more accurate diagnosis, improving rational drug prescription and 
decreasing the burden on the tertiary healthcare system should be 
evaluated. A patient­centred approach can also evaluate patients’ own 
perception of impact on their illness.
Conclusion
Echocardiography had a positive impact on patient management in 
a district hospital setting. Limited access for patients may negatively 
impact on their management, as a valuable contribution of TTEs 
to overall management was found. A normal ECHO is important 
in offering reassurance to patients and diagnostic assistance to the 
referring doctor, and aiding in referral back to the primary level of 
care. In the overburdened public health sector, where continuity 
of care is frequently a problem, it may reduce time and costs. By 
providing an ECHO service in non­tertiary settings, patients can 
be screened and more appropriately referred to scarce upstream 
specialists and subspecialist departments.
Training in interpretation and accreditation in the use of ECHO 
should be a priority for teaching and academic facilities, especially 
for personnel working in general, emergency and family medicine. 
The prospect of hand­held devices would definitely enhance access, 
but may compromise quality.
Policy makers should be alerted to the added value offered by an 
ECHO assessment. The rapidly growing burden of NCDs should 
encourage investment in such service­based interventions to local 
communities.[4] District hospitals can establish protocols in the 
communities they serve, to assist with procurement and referrals 
from primary health care.
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